Search - tctmd.com

Displaying 181 - 199 of 199

Sort: Relevancy | Date

News Daily News

Una Mayor Regresión Precoz de la Masa VI Post-TAVR Reduce las Rehospitalizaciones

June 27, 2014

Presentation

Early Regression of Severe LV Hypertrophy After TAVR Is Associated with Decreased Hospitalizations

Presenter: Brian R. Lindman

June 25, 2014

News Daily News

Study Questions Ability of TAVR to Improve Psychological, General Health

L.A. McKeown

March 13, 2014

News Daily News

COPD Common in TAVR Patients, Associated with Increased CV Mortality

Jason Kahn

March 06, 2014

News Daily News

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Jason Kahn

January 16, 2014

News Daily News

Fever After TAVR Common, but Antibiotics Rarely Needed

L.A. McKeown

January 15, 2014

News Daily News

Early TAVR Results Match PARTNER Outcomes, But With Fewer Complications

Jason Kahn

January 01, 2014

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

Drop in Platelet Count After TAVR Signals Poor Outcomes

Caitlin E. Cox

June 18, 2013

News Conference News ACC 2013

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

L.A. McKeown

March 11, 2013

News Daily News

Persistent LBBB After CoreValve Implantation Associated With Need for Pacemaker

February 28, 2013

News Daily News

Persistent Left Bundle Branch Block after TAVR Linked to Ventricular Dysfunction

October 04, 2012

News Conference News ESC 2012

TAVR Improves Quality of Life, Reduces Hospitalization in German Registry

Yael L. Maxwell

August 28, 2012

News Daily News

Permanent Pacemaker After TAVR Does Not Worsen Hard Outcomes

Caitlin E. Cox

June 21, 2012

News

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

TCT Daily Staff

September 23, 2010

CME

Advertisement

Una Mayor Regresión Precoz de la Masa VI Post-TAVR Reduce las Rehospitalizaciones

Early Regression of Severe LV Hypertrophy After TAVR Is Associated with Decreased Hospitalizations

Study Questions Ability of TAVR to Improve Psychological, General Health

COPD Common in TAVR Patients, Associated with Increased CV Mortality

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Fever After TAVR Common, but Antibiotics Rarely Needed

Early TAVR Results Match PARTNER Outcomes, But With Fewer Complications

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

Drop in Platelet Count After TAVR Signals Poor Outcomes

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

Persistent LBBB After CoreValve Implantation Associated With Need for Pacemaker

Persistent Left Bundle Branch Block after TAVR Linked to Ventricular Dysfunction

TAVR Improves Quality of Life, Reduces Hospitalization in German Registry

Permanent Pacemaker After TAVR Does Not Worsen Hard Outcomes

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

Updates on TAVR in Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content